Concepedia

Publication | Closed Access

Tremelimumab combined with durvalumab in patients with mesothelioma (NIBIT-MESO-1): an open-label, non-randomised, phase 2 study

210

Citations

19

References

2018

Year

References

YearCitations

Page 1